In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Vaxcyte Inc (NASDAQ: PCVX) closed at $102.70 down -1.32% from its previous closing price of $104.07. In other words, the price has decreased by -$1.32 from its previous closing price. On the day, 1.2 million shares were traded. PCVX stock price reached its highest trading level at $106.82 during the session, while it also had its lowest trading level at $101.87.
Ratios:
For a deeper understanding of Vaxcyte Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.88 and its Current Ratio is at 17.88. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on December 07, 2023, initiated with a Buy rating and assigned the stock a target price of $69.
Needham reiterated its Buy rating for the stock on January 03, 2023, while the target price for the stock was revised from $52 to $58.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 07 ’24 when PICKERING GRANT bought 2,366 shares for $104.08 per share.
Eydelman Mikhail sold 5,000 shares of PCVX for $531,803 on Nov 05 ’24. The SVP, GEN COUNSEL & CORP SEC now owns 28,623 shares after completing the transaction at $106.36 per share. On Nov 05 ’24, another insider, Eydelman Mikhail, who serves as the Officer of the company, bought 5,000 shares for $105.18 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PCVX now has a Market Capitalization of 12968441856 and an Enterprise Value of 10647667712.
Stock Price History:
Over the past 52 weeks, PCVX has reached a high of $121.06, while it has fallen to a 52-week low of $46.16. The 50-Day Moving Average of the stock is -7.48%, while the 200-Day Moving Average is calculated to be 25.23%.
Shares Statistics:
For the past three months, PCVX has traded an average of 950.96K shares per day and 929270 over the past ten days. A total of 121.80M shares are outstanding, with a floating share count of 117.28M. Insiders hold about 3.71% of the company’s shares, while institutions hold 98.32% stake in the company. Shares short for PCVX as of 1728950400 were 9344117 with a Short Ratio of 9.83, compared to 1726185600 on 9705810. Therefore, it implies a Short% of Shares Outstanding of 9344117 and a Short% of Float of 8.58.
